Search Results - "Wei, John T"

Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms by Sarma, Aruna V, Wei, John T

“…Lower urinary tract symptoms affect more than half of older men. Options for bothersome symptoms include α-adrenergic-receptor blockers, 5α-reductase…”
Get full text

Beyond PSA: the next generation of prostate cancer biomarkers by Prensner, John R, Rubin, Mark A, Wei, John T, Chinnaiyan, Arul M

“…Since the introduction of serum prostate-specific antigen (PSA) screening 25 years ago, prostate cancer diagnosis and management have been guided by this…”
Get more information

Radical Prostatectomy versus Observation for Localized Prostate Cancer by Wilt, Timothy J, Brawer, Michael K, Jones, Karen M, Barry, Michael J, Aronson, William J, Fox, Steven, Gingrich, Jeffrey R, Wei, John T, Gilhooly, Patricia, Grob, B. Mayer, Nsouli, Imad, Iyer, Padmini, Cartagena, Ruben, Snider, Glenn, Roehrborn, Claus, Sharifi, Roohollah, Blank, William, Pandya, Parikshit, Andriole, Gerald L, Culkin, Daniel, Wheeler, Thomas

“…Over 700 men were assigned to radical prostatectomy or observation after receiving a diagnosis of prostate cancer, usually on the basis of elevated PSA levels…”
Get full text

Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression by Zhang, Yajia, Pitchiaya, Sethuramasundaram, Cieślik, Marcin, Niknafs, Yashar S., Tien, Jean C.-Y., Hosono, Yasuyuki, Iyer, Matthew K., Yazdani, Sahr, Subramaniam, Shruthi, Shukla, Sudhanshu K., Jiang, Xia, Wang, Lisha, Liu, Tzu-Ying, Uhl, Michael, Gawronski, Alexander R., Qiao, Yuanyuan, Xiao, Lanbo, Dhanasekaran, Saravana M., Juckette, Kristin M., Kunju, Lakshmi P., Cao, Xuhong, Patel, Utsav, Batish, Mona, Shukla, Girish C., Paulsen, Michelle T., Ljungman, Mats, Jiang, Hui, Mehra, Rohit, Backofen, Rolf, Sahinalp, Cenk S., Freier, Susan M., Watt, Andrew T., Guo, Shuling, Wei, John T., Feng, Felix Y., Malik, Rohit, Chinnaiyan, Arul M.

“…The androgen receptor (AR) plays a critical role in the development of the normal prostate as well as prostate cancer. Using an integrative transcriptomic…”
Get full text

Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1 , an unannotated lincRNA implicated in disease progression by Chinnaiyan, Arul M, Prensner, John R, Iyer, Matthew K, Balbin, O Alejandro, Dhanasekaran, Saravana M, Cao, Qi, Brenner, J Chad, Laxman, Bharathi, Asangani, Irfan A, Grasso, Catherine S, Kominsky, Hal D, Cao, Xuhong, Jing, Xiaojun, Wang, Xiaoju, Siddiqui, Javed, Wei, John T, Robinson, Daniel, Iyer, Hari K, Palanisamy, Nallasivam, Maher, Christopher A

“…New noncoding RNAs can be discovered by assembling transcripts from RNA-Seq data. Prensner et al . apply this approach across >100 prostate cancer samples to…”
Get full text

A Midurethral Sling to Reduce Incontinence after Vaginal Prolapse Repair by Wei, John T, Nygaard, Ingrid, Richter, Holly E, Nager, Charles W, Barber, Matthew D, Kenton, Kim, Amundsen, Cindy L, Schaffer, Joseph, Meikle, Susan F, Spino, Cathie

“…Women undergoing surgery for vaginal prolapse are at risk for urinary incontinence. In this randomized trial, women who received a midurethral sling had lower…”
Get full text

The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer by Loeb, Stacy, Sanda, Martin G, Broyles, Dennis L, Shin, Sanghyuk S, Bangma, Chris H, Wei, John T, Partin, Alan W, Klee, George G, Slawin, Kevin M, Marks, Leonard S, van Schaik, Ron H.N, Chan, Daniel W, Sokoll, Lori J, Cruz, Amabelle B, Mizrahi, Isaac A, Catalona, William J

“…Purpose The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now…”
Get full text

Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form by Skolarus, Ted A, Dunn, Rodney L, Sanda, Martin G, Chang, Peter, Greenfield, Thomas K, Litwin, Mark S, Wei, John T

“…Objective To establish a score threshold that constitutes a clinically relevant change for each domain of the Expanded Prostate Cancer Index Composite (EPIC)…”
Get full text

Can urinary PCA3 supplement PSA in the early detection of prostate cancer? by Wei, John T, Feng, Ziding, Partin, Alan W, Brown, Elissa, Thompson, Ian, Sokoll, Lori, Chan, Daniel W, Lotan, Yair, Kibel, Adam S, Busby, J Erik, Bidair, Mohamed, Lin, Daniel W, Taneja, Samir S, Viterbo, Rosalia, Joon, Aron Y, Dahlgren, Jackie, Kagan, Jacob, Srivastava, Sudhir, Sanda, Martin G

“…Given the limited sensitivity and specificity of prostate-specific antigen (PSA), its widespread use as a screening tool has raised concerns for the…”
Get full text

AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points by Stoffel, John T, Peterson, Andrew C, Sandhu, Jaspreet S, Suskind, Anne M, Wei, John T, Lightner, Deborah J

“…Purpose The AUA (American Urological Association) QIPS (Quality Improvement and Patient Safety) committee created a white paper on the diagnosis and management…”
Get full text

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 by Prensner, John R, MD, Zhao, Shuang, MSc, Erho, Nicholas, MSc, Schipper, Matthew, PhD, Iyer, Matthew K, PhD, Dhanasekaran, Saravana M, PhD, Magi-Galluzzi, Cristina, MD, Mehra, Rohit, MD, Sahu, Anirban, BSc, Siddiqui, Javed, MSc, Davicioni, Elai, PhD, Den, Robert B, MD, Dicker, Adam P, Prof, Karnes, R Jeffrey, MD, Wei, John T, Prof, Klein, Eric A, Prof, Jenkins, Robert B, Prof, Chinnaiyan, Arul M, Prof, Feng, Felix Y, Dr

“…Summary Background Improved clinical predictors for disease progression are needed for localised prostate cancer, since only a subset of patients develop…”
Get full text

Prediction of Erectile Function Following Treatment for Prostate Cancer by Alemozaffar, Mehrdad, Regan, Meredith M, Cooperberg, Matthew R, Wei, John T, Michalski, Jeff M, Sandler, Howard M, Hembroff, Larry, Sadetsky, Natalia, Saigal, Christopher S, Litwin, Mark S, Klein, Eric, Kibel, Adam S, Hamstra, Daniel A, Pisters, Louis L, Kuban, Deborah A, Kaplan, Irving D, Wood, David P, Ciezki, Jay, Dunn, Rodney L, Carroll, Peter R, Sanda, Martin G

“…CONTEXT Sexual function is the health-related quality of life (HRQOL) domain most commonly impaired after prostate cancer treatment; however, validated tools…”
Get full text

Medical therapy to facilitate urinary stone passage: a meta-analysis by Hollingsworth, John M, Rogers, Mary AM, Kaufman, Samuel R, Bradford, Timothy J, Saint, Sanjay, Wei, John T, Hollenbeck, Brent K

“…Medical therapies to ease urinary-stone passage have been reported, but are not generally used. If effective, such therapies would increase the options for…”
Get full text

Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence by Cole, Adam I, Morgan, Todd M, Spratt, Daniel E, Palapattu, Ganesh S, He, Chang, Tomlins, Scott A, Weizer, Alon Z, Feng, Felix Y, Wu, Angela, Siddiqui, Javed, Chinnaiyan, Arul M, Montgomery, Jeffrey S, Kunju, Lakshmi P, Miller, David C, Hollenbeck, Brent K, Wei, John T, Mehra, Rohit

“…Purpose The importance of primary Gleason grade among men with Gleason score 7 disease has been well-defined. However, this dichotomization may oversimplify…”
Get full text

Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer by Jacobs, Bruce L, Zhang, Yun, Schroeck, Florian R, Skolarus, Ted A, Wei, John T, Montie, James E, Gilbert, Scott M, Strope, Seth A, Dunn, Rodney L, Miller, David C, Hollenbeck, Brent K

“…IMPORTANCE The use of advanced treatment technologies (ie, intensity-modulated radiotherapy [IMRT] and robotic prostatectomy) for prostate cancer is…”
Get full text

A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer by LAXMAN, Bharathi, MORRIS, David S, CHINNAIYAN, Arul M, JIANJUN YU, SIDDIQUI, Javed, JIE CAO, MEHRA, Rohit, LONIGRO, Robert J, TSODIKOV, Alex, WEI, John T, TOMLINS, Scott A

“…Although prostate-specific antigen (PSA) serum level is currently the standard of care for prostate cancer screening in the United States, it lacks ideal…”
Get full text

Nocturia and Quality of Life: Results from the Boston Area Community Health Survey by Kupelian, Varant, Wei, John T, O'Leary, Michael P, Norgaard, Jens Peter, Rosen, Raymond C, McKinlay, John B

“…Abstract Background Nocturia, a common complaint in aging men and women, is frequently cited as the cause of nocturnal awakenings leading to sleep loss,…”
Get full text

The Role of Sarcosine Metabolism in Prostate Cancer Progression by Khan, Amjad P, Rajendiran, Thekkelnaycke M, Bushra, Ateeq, Asangani, Irfan A, Athanikar, Jyoti N, Yocum, Anastasia K, Mehra, Rohit, Siddiqui, Javed, Palapattu, Ganesh, Wei, John T, Michailidis, George, Sreekumar, Arun, Chinnaiyan, Arul M

“…Abstract Metabolomic profiling of prostate cancer (PCa) progression identified markedly elevated levels of sarcosine ( N -methyl glycine) in metastatic PCa and…”
Get full text

Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer by Filson, Christopher P, Schroeck, Florian R, Ye, Zaojun, Wei, John T, Hollenbeck, Brent K, Miller, David C

“…We examined variation in active surveillance use in Medicare eligible men undergoing expectant treatment for early stage prostate cancer. Using SEER…”
Get more information

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer by Salami, Simpa S., M.D, M.P.H, Schmidt, Folke, M.D, Laxman, Bharathi, Ph.D, Regan, Meredith M., Sc.D, Rickman, David S., Ph.D, Scherr, Douglas, M.D, Bueti, Gerardina, B.S, Siddiqui, Javed, M.S, Tomlins, Scott A., M.D., Ph.D, Wei, John T., M.D., M.S, Chinnaiyan, Arul M., M.D., Ph.D, Rubin, Mark A., M.D, Sanda, Martin G., M.D

“…Abstract Objectives We sought to develop a clinical algorithm combining serum PSA with detection of TMPRSS2:ERG fusion and PCA3 in urine collected after…”
Get full text